Home › Therapeutic areas › Neurology › Friedreich's Ataxia
Friedreich's Ataxia (4 companies)
Companies with an active program in Friedreich's Ataxia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics | Neurology Rare | 1 | NDA Submitted | $248M | 1 |
| LXEO | Lexeo Therapeutics | CardiovascularNeurology Rare | 5 | Phase 2 | $237M | 12 |
| SLDB | Solid Biosciences | CardiovascularNeurology Rare | 1 | Phase 3 | $736M | 6 |
| VYGR | Voyager Therapeutics | MetabolicNeurology Rare | 1 | Phase 1 | $116M | 9 |
No companies match.